Innova Captab — 360° view

Innova Captab, a company in the Pharmaceuticals industry, reported revenue of ₹471 crore and net profit of ₹44 crore for the June 2026 quarter.

Innova Captab (NSE: INNOVACAP) closed at ₹977.80 on 20 Nov 2026, up 33.5% over the past year. Its market capitalisation is ₹5,595 crore and it trades at 33.5 times earnings.

Share price
₹977.80 (20 Nov 2026)
Market cap
₹5,595 Cr (20 Nov 2026)
P/E
33.55 (20 Nov 2026)
Revenue
₹471 Cr (June 2026 quarter)
Net profit
₹44 Cr (June 2026 quarter)
ROCE
15.0% (FY26)
ROE
13.7% (FY26)
Book value
₹191 (FY26)
Dividend yield
0.20% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,353.50 / ₹622.00 (20 Nov 2026)
1-year return
33.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: INNOVACAP

Incorporated in January 2005, Innova Captab Ltd is a pharmaceutical company is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.